Identification and utility of innate immune system evasion mechanisms of ASFV

Virus Research

Volumn 173, Issue 1, 2013, Pages 87-100

  Correia, Sílvia ^a   Ventura, Sónia ^a   Parkhouse, Robert Michael ^a  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

ASFV; Immune evasion; Interferon; Non homologous virus gene; TLR; Vaccine

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CRK LIKE PROTEIN; DOUBLE STRANDED RNA; ENHANCEOSOME; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 24; JANUS KINASE; MYELOID DIFFERENTIATION FACTOR 88; RETINOIC ACID INDUCIBLE PROTEIN I; STAT1 PROTEIN; STAT2 PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; AFRICAN SWINE FEVER VIRUS; ANTIGEN RECOGNITION; CYTOKINE RELEASE; DIMERIZATION; DOWN REGULATION; EXTRACELLULAR SPACE; IMMUNE EVASION; IMMUNOMODULATION; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY;

AFRICAN SWINE FEVER VIRUS; ANIMALS; HOST-PATHOGEN INTERACTIONS; IMMUNE EVASION; IMMUNITY, INNATE; INTERFERONS; MICE; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; SWINE; VIRAL PROTEINS; VIRULENCE FACTORS;

AFRICAN SWINE FEVER VIRUS; MUS; MUS MUSCULUS; SUIDAE;

EID: 84875624761     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.10.013     Document Type: Review

References (107)

1. Abrams C.C., Dixon L.K. Sequential deletion of genes from the African swine fever virus genome using the cre/loxP recombination system. Virology 2012, 433(1):142-148.
2. Afonso C.L., Piccone M.E., Zaffuto K.M., Neilan J., Kutish G.F., Lu Z., Balinsky C.A., Gibb T.R., Bean T.J., Zsak L., Rock D.L. African swine fever virus multigene family 360 and 530 genes affect host interferon response. Journal of Virology 2004, 78(4):1858-1864.
3. Akira S., Takeda K. Toll-like receptor signalling. Nature Reviews Immunology 2004, 4(7):499-511.
4. Alcami A., Smith G.L. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. Journal of Virology 1995, 69(8):4633-4639.
5. Almeida S.C., de Oliveira V.L., Ventura S., Bofill M., Parkhouse R.M. Neoplastic transformation of T lymphocytes through transgenic expression of a virus host modification protein. PLoS One 2012, 7(4):e34140.
6. Alzhanova D., Fruh K. Modulation of the host immune response by cowpox virus. Microbes and Infection 2010, 12(12-13):900-909.
7. Ashour J., Laurent-Rolle M., Shi P.-Y., García-Sastre A. NS5 of Dengue virus mediates STAT2 binding and degradation. Journal of Virology 2009, 83(11):5408-5418.
8. Bahar M.W., Graham S.C., Chen R.A.J., Cooray S., Smith G.L., Stuart D.I., Grimes J.M. How vaccinia virus has evolved to subvert the host immune response. Journal of Structural Biology 2011, 175(2):127-134.
9. Bilgin D.D., Liu Y., Schiff M., Dinesh-Kumar S.P. P58(IPK), a plant ortholog of double-stranded RNA-dependent protein kinase PKR inhibitor, functions in viral pathogenesis. Developmental Cell 2003, 4(5):651-661.
10. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to Interferon-gamma. Annual Review of Immunology 1997, 15:749-795.
11. Brierley M.M., Fish E.N. Stats: multifaceted regulators of transcription. Journal of Interferon and Cytokine Research 2005, 25(12):733-744.
12. BurýŠek L., Pitha P.M. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. Journal of Virology 2001, 75(5):2345-2352.
13. Chelbi-Alix M.K., Wietzerbin J. Interferon, a growing cytokine family: 50 years of interferon research. Biochimie 2007, 89(6-7):713-718.
14. Christensen J.E., Thomsen A.R. Co-ordinating innate and adaptive immunity to viral infection: mobility is the key. APMIS 2009, 117(5-6):338-355.
15. Darwich L., Coma G., Peña R., Bellido R., Blanco E.J.J., Este J.A., Borras F.E., Clotet B., Ruiz L., Rosell A., Andreo F., Parkhouse R.M.E., Bofill M. Secretion of Interferon-γ by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18. Immunology 2009, 126(3):386-393.
16. de Oliveira V.L., Almeida S.C., Soares H.R., Crespo A., Marshall-Clarke S., Parkhouse R.M. A novel TLR3 inhibitor encoded by African swine fever virus (ASFV). Archives of Virology 2011, 156(4):597-609.
17. Di Lorenzo C., Angus A.G., Patel A.H. Hepatitis C virus evasion mechanisms from neutralizing antibodies. Viruses 2011, 3(11):2280-2300.
18. Diebold S. Innate recognition of viruses. Immunology Letters 2010, 128(1):17-20.
19. Donnelly R.P., Kotenko S.V. Interferon-lambda: a new addition to an old family. Journal of Interferon and Cytokine Research 2010, 30(8):555-564.
20. Droescher M., Begitt A., Marg A., Zacharias M., Vinkemeier U. Cytokine-induced paracrystals prolong the activity of Signal Transducers and Activators of Transcription (STAT) and provide a model for the regulation of protein solubility by Small Ubiquitin-like Modifier (SUMO). Journal of Biological Chemistry 2011, 286(21):18731-18746.
21. Elia A., Laing K.G., Schofield A., Tilleray V.J., Clemens M.J. Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome. Nucleic Acids Research 1996, 24(22):4471-4478.
22. Engel P., Angulo A. Viral immunomodulatory proteins: usurping host genes as a survival strategy. Advances in Experimental Medicine and Biology 2012, 738:256-276.
23. Fischl W., Bartenschlager R. Exploitation of cellular pathways by Dengue virus. Current Opinion in Microbiology 2011, 14(4):470-475.
24. Gack M.U., Albrecht R.A., Urano T., Inn K.-S., Huang I.C., Carnero E., Farzan M., Inoue S., Jung J.U., García-Sastre A. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host & Microbe 2009, 5(5):439-449.
25. Gale M.J., Korth M.J., Tang N.M., Tan S.L., Hopkins D.A., Dever T.E., Polyak S.J., Gretch D.R., Katze M.G. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997, 230(2):217-227.
26. Garcia-Rodriguez C., Rao A. Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP). Journal of Experimental Medicine 1998, 187(12):2031-2036.
27. Garcia-Sastre A. De-ISGylating and de-ubiquitinating activities of viral OUT-like proteins. Gordon Research Conference 2007: Viruses and Cells, Tilton School 2007, Tilton, NH, USA.
28. Gerritsen M.E., Williams A.J., Neish A.S., Moore S., Shi Y., Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(7):2927-2932.
29. Gomez-Puertas P., Escribano J.M. Blocking antibodies inhibit complete African swine fever virus neutralization. Virus Research 1997, 49(2):115-122.
30. Goodbourn S., Randall R.E. The regulation of type I interferon production by paramyxoviruses. Journal of Interferon and Cytokine Research 2009, 29(9):539-547.
31. Goodman A.G., Smith J.A., Balachandran S., Perwitasari O., Proll S.C., Thomas M.J., Korth M.J., Barber G.N., Schiff L.A., Katze M.G. The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism. Journal of Virology 2007, 81(5):2221-2230.
32. Granja A.G., Nogal M.L., Hurtado C., Del Aguila C., Carrascosa A.L., Salas M.L., Fresno M., Revilla Y. The viral protein A238L inhibits TNF-alpha expression through a CBP/p300 transcriptional coactivators pathway. Journal of Immunology 2006, 176(1):451-462.
33. Granja A.G., Nogal M.L., Hurtado C., Vila V., Carrascosa A.L., Salas M.L., Fresno M., Revilla Y. The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway. Journal of Biological Chemistry 2004, 279(51):53736-53746.
34. Granja A.G., Perkins N.D., Revilla Y. A238L inhibits NF-ATc2, NF-kappaB, and c-Jun activation through a novel mechanism involving protein kinase C-theta-mediated up-regulation of the amino-terminal transactivation domain of p300. Journal of Immunology 2008, 180(4):2429-2442.
35. Granja A.G., Sabina P., Salas M.L., Fresno M., Revilla Y. Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation. Journal of Virology 2006, 80(21):10487-10496.
36. Granja A.G., Sanchez E.G., Sabina P., Fresno M., Revilla Y. African swine fever virus blocks the host cell antiviral inflammatory response through a direct inhibition of PKC-theta-mediated p300 transactivation. Journal of Virology 2009, 83(2):969-980.
37. Gunnery S., Rice A.P., Robertson H.D., Mathews M.B. Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proceedings of the National Academy of Sciences of the United States of America 1990, 87(22):8687-8691.
38. Guo H., Mi Z., Bowles D.E., Bhattacharya S.D., Kuo P.C. Osteopontin and protein kinase C regulate PDLIM2 activation and STAT1 ubiquitination in LPS-treated murine macrophages. Journal of Biological Chemistry 2010, 285(48):37787-37796.
39. Haller O., Staeheli P., Kochs G. Protective role of interferon-induced Mx GTPases against influenza viruses. Revue Scientifique et Technique 2009, 28(1):219-231.
40. Hardy M.P., Owczarek C.M., Jermiin L.S., Ejdebäck M., Hertzog P.J. Characterization of the type I Interferon locus and identification of novel genes. Genomics 2004, 84(2):331-345.
41. Henriques E.S., Brito R.M., Soares H., Ventura S., de Oliveira V.L., Parkhouse R.M. Modeling of the Toll-like receptor 3 and a putative Toll-like receptor 3 antagonist encoded by the African swine fever virus. Protein Science 2011, 20(2):247-255.
42. Hervas-Stubbs S., Perez-Gracia J.L., Rouzaut A., Sanmamed M.F., Le Bon A., Melero I. Direct effects of type I interferons on cells of the immune system. Clinical Cancer Research 2011, 17(9):2619-2627.
43. Hilton L., Moganeradj K., Zhang G., Chen Y.-H., Randall R.E., McCauley J.W., Goodbourn S. The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. Journal of Virology 2006, 80(23):11723-11732.
44. Honda K., Takaoka A., Taniguchi T. Type I Interferon gene induction by the Interferon regulatory factor family of transcription factors. Immunity 2006, 25(3):349-360.
45. Honda K., Yanai H., Takaoka A., Taniguchi T. Regulation of the type I IFN induction: a current view. International Immunology 2005, 17(11):1367-1378.
46. Husebye H., Halaas O., Stenmark H., Tunheim G., Sandanger O., Bogen B., Brech A., Latz E., Espevik T. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO Journal 2006, 25(4):683-692.
47. Jackson S.E., Mason G.M., Wills M.R. Human cytomegalovirus immunity and immune evasion. Virus Research 2011, 157(2):151-160.
48. Jenson J.S., Childerstone A., Takamatsu H., Dixon L.K., Parkhouse R.M. The cellular immune recognition of proteins expressed by an African swine fever virus random genomic library. Journal of Immunological Methods 2000, 242(1-2):33-42.
49. Kagan J.C., Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 2006, 125(5):943-955.
50. Kagan J.C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nature Immunology 2008, 9(4):361-368.
51. Karalyan Z., Zakaryan H., Sargsyan K., Voskanyan H., Arzumanyan H., Avagyan H., Karalova E. Interferon status and white blood cells during infection withs African swine fever virus in vivo. Veterinary Immunology and Immunopathology 2012, 145(1-2):551-555.
52. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34(5):637-650.
53. Kerur N., Veettil Mohanan V., Sharma-Walia N., Bottero V., Sadagopan S., Otageri P., Chandran B. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-associated herpesvirus infection. Cell Host & Microbe 2011, 9(5):363-375.
54. King P., Goodbourn S. The beta-interferon promoter responds to priming through multiple independent regulatory elements. Journal of Biological Chemistry 1994, 269(48):30609-30615.
55. Kisseleva T., Bhattacharya S., Braunstein J., Schindler C.W. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 2002, 285(1-2):1-24.
56. Kollnberger S.D., Gutierrez-Castaneda B., Foster-Cuevas M., Corteyn A., Parkhouse R.M. Identification of the principal serological immunodeterminants of African swine fever virus by screening a virus cDNA library with antibody. Journal of General Virology 2002, 83(Pt 6):1331-1342.
57. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., Donnelly R.P. IFN-[lambda]s mediate antiviral protection through a distinct class II cytokine receptor complex. Nature Immunology 2003, 4(1):69-77.
58. La Rocca S.A., Herbert R.J., Crooke H., Drew T.W., Wileman T.E., Powell P.P. Loss of interferon regulatory factor 3 in cells infected with classical swine fever virus involves the N-terminal protease, Npro. Journal of Virology 2005, 79(11):7239-7247.
59. Le Bon A., Tough D.F. Type I interferon as a stimulus for cross-priming. Cytokine and Growth Factor Reviews 2008, 19(1):33-40.
60. Leitao A., Cartaxeiro C., Coelho R., Cruz B., Parkhouse R.M., Portugal F., Vigario J.D., Martins C.L. The non-haemadsorbing African swine fever virus isolate ASFV/NH/P68 provides a model for defining the protective anti-virus immune response. Journal of General Virology 2001, 82(Pt 3):513-523.
61. Levy D.E., Darnell J.E. Stats: transcriptional control and biological impact. Nature Reviews Molecular Cell Biology 2002, 3(9):651-662.
62. Levy D.E., Marié I.J., Durbin J.E. Induction and function of type I and III interferon in response to viral infection. Current Opinion in Virology 2011, 1(6):476-486.
63. Malmgaard L. Induction and regulation of IFNs during viral infections. Journal of Interferon and Cytokine Research 2004, 24(8):439-454.
64. Mathews M.B., Shenk T. Adenovirus virus-associated RNA and translation control. Journal of Virology 1991, 65(11):5657-5662.
65. Medyouf H., Alcalde H., Berthier C., Guillemin M.C., dos Santos N.R., Janin A., Decaudin D., de The H., Ghysdael J. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nature Medicine 2007, 13(6):736-741.
66. Miskin J.E., Abrams C.C., Dixon L.K. African swine fever virus protein A238L interacts with the cellular phosphatase calcineurin via a binding domain similar to that of NFAT. Journal of Virology 2000, 74(20):9412-9420.
67. Miskin J.E., Abrams C.C., Goatley L.C., Dixon L.K. A viral mechanism for inhibition of the cellular phosphatase calcineurin. Science 1998, 281(5376):562-565.
68. Moller A., Schmitz M.L. Viruses as hijackers of PML nuclear bodies. Archivum Immunologiae et Therapiae Experimentalis 2003, 51(5):295-300.
69. Mosca J.D., Pitha P.M. Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis. Molecular and Cellular Biology 1986, 6(6):2279-2283.
70. Mukherjee A., Morosky S.A., Delorme-Axford E., Dybdahl-Sissoko N., Oberste M.S., Wang T., Coyne C.B. The Coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I Interferon and apoptotic signaling. PLoS Pathogens 2011, 7(3):e1001311.
71. Murray P.J. The JAK-STAT signaling pathway: input and output integration. Journal of Immunology 2007, 178(5):2623-2629.
72. Nyman T., Stenmark P., Flodin S., Johansson I., Hammarstrom M., Nordlund P. The crystal structure of the human toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. Journal of Biological Chemistry 2008, 283(18):11861-11865.
73. Okumura A., Alce T., Lubyova B., Ezelle H., Strebel K., Pitha P.M. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 2008, 373(1):85-97.
74. Onoguchi K., Yoneyama M., Takemura A., Akira S., Taniguchi T., Namiki H., Fujita T. Viral infections activate types I and III interferon genes through a common mechanism. Journal of Biological Chemistry 2007, 282(10):7576-7581.
75. Osterlund P.I., Pietila T.E., Veckman V., Kotenko S.V., Julkunen I. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. Journal of Immunology 2007, 179(6):3434-3442.
76. Paun A., Pitha P.M. The IRF family, revisited. Biochimie 2007, 89(6-7):744-753.
77. Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., Nabel G.J. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 1997, 275(5299):523-527.
78. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nature Reviews Immunology 2005, 5(5):375-386.
79. Powell P.P., Dixon L.K., Parkhouse R.M. An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. Journal of Virology 1996, 70(12):8527-8533.
80. Qi R., Singh D., Kao C.C. Proteolytic processing regulates Toll-like receptor 3 stability and endosomal localization. Journal of Biological Chemistry 2012, 287(39):32617-32629.
81. Qu L., Feng Z., Yamane D., Liang Y., Lanford R.E., Li K., Lemon S.M. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathogens 2011, 7(9):e1002169.
82. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. Journal of General Virology 2008, 89(Pt 1):1-47.
83. Reid S.P., Leung L.W., Hartman A.L., Martinez O., Shaw M.L., Carbonnelle C., Volchkov V.E., Nichol S.T., Basler C.F. Ebola virus VP24 binds karyopherin α1 and blocks STAT1 nuclear accumulation. Journal of Virology 2006, 80(11):5156-5167.
84. Revilla Y., Callejo M., Rodriguez J.M., Culebras E., Nogal M.L., Salas M.L., Vinuela E., Fresno M. Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein. Journal of Biological Chemistry 1998, 273(9):5405-5411.
85. Roberts L.O., Jopling C.L., Jackson R.J., Willis A.E. Chapter 9 - viral strategies to subvert the mammalian translation machinery. Progress in Molecular Biology and Translational Science 2009, 90:313-367. http://www.sciencedirect.com/science/article/pii/S1877117309900096.
86. Schmidt D., Muller S. PIAS/SUMO: new partners in transcriptional regulation. Cellular and Molecular Life Sciences 2003, 60(12):2561-2574.
87. Stack J., Bowie A.G. Poxviral protein A46 antagonizes Toll-like receptor 4 signaling by targeting BB loop motifs in Toll-IL-1 receptor adaptor proteins to disrupt receptor: adaptor interactions. Journal of Biological Chemistry 2012, 287(27):22672-22682.
88. Stack J., Haga I.R., Schroder M., Bartlett N.W., Maloney G., Reading P.C., Fitzgerald K.A., Smith G.L., Bowie A.G. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. Journal of Experimental Medicine 2005, 201(6):1007-1018.
89. Stetson D.B., Medzhitov R. Type I interferons in host defense. Immunity 2006, 25(3):373-381.
90. Taylor D.R., Shi S.T., Romano P.R., Barber G.N., Lai M.M. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 1999, 285(5424):107-110.
91. Thomson S.J., Goh F.G., Banks H., Krausgruber T., Kotenko S.V., Foxwell B.M., Udalova I.A. The role of transposable elements in the regulation of IFN-lambda1 gene expression. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(28):11564-11569.
92. Toshchakov V.Y., Fenton M.J., Vogel S.N. Cutting edge: differential inhibition of TLR signaling pathways by cell-permeable peptides representing BB loops of TLRs. Journal of Immunology 2007, 178(5):2655-2660.
93. Unterholzner L., Bowie A.G. The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities. Biochemical Pharmacology 2008, 75(3):589-602.
94. Vallee I., Tait S.W., Powell P.P. African swine fever virus infection of porcine aortic endothelial cells leads to inhibition of inflammatory responses, activation of the thrombotic state, and apoptosis. Journal of Virology 2001, 75(21):10372-10382.
95. van Boxel-Dezaire A.H., Rani M.R., Stark G.R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 2006, 25(3):361-372.
96. Vercammen E., Staal J., Beyaert R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clinical Microbiology Reviews 2008, 21(1):13-25.
97. Versteeg G.A., García-Sastre A. Viral tricks to grid-lock the type I Interferon system. Current Opinion in Microbiology 2010, 13(4):508-516.
98. Visvanathan K.V., Goodbourn S. Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter. EMBO Journal 1989, 8(4):1129-1138.
99. Viswanathan K., Früh K., DeFilippis V. Viral hijacking of the host ubiquitin system to evade interferon responses. Current Opinion in Microbiology 2010, 13(4):517-523.
100. Vyas J., Elia A., Clemens M.J. Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA. RNA 2003, 9(7):858-870.
101. Weber F., Haller O. Viral suppression of the interferon system. Biochimie 2007, 89(6-7):836-842.
102. Whittall J.T., Parkhouse R.M. Changes in swine macrophage phenotype after infection with African swine fever virus: cytokine production and responsiveness to interferon-gamma and lipopolysaccharide. Immunology 1997, 91(3):444-449.
103. Wilkins C., Gale M. Recognition of viruses by cytoplasmic sensors. Current Opinion in Immunology 2010, 22(1):41-47.
104. Young H.A., Bream J.H. IFN-gamma: recent advances in understanding regulation of expression, biological functions, and clinical applications. Current Topics in Microbiology and Immunology 2007, 316:97-117.
105. Yuan W., Krug R.M. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO Journal 2001, 20(3):362-371.
106. Zhang F., Hopwood P., Abrams C.C., Downing A., Murray F., Talbot R., Archibald A., Lowden S., Dixon L.K. Macrophage transcriptional responses following in vitro infection with a highly virulent African swine fever virus isolate. Journal of Virology 2006, 80(21):10514-10521.
107. Zimnik S., Gaestel M., Niedenthal R. Mutually exclusive STAT1 modifications identified by Ubc9/substrate dimerization-dependent SUMOylation. Nucleic Acids Research 2009, 37(4):e30.